##### ยง 1321.01 DEA mailing addresses. #####

The following table provides information regarding mailing addresses to be used when sending specified correspondence to the Drug Enforcement Administration.

Table of DEA Mailing Addresses

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Code of Federal Regulations Section - Topic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                         DEA mailing address                                                                                          |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DEA Administrator                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1308.43(b) - Petition to initiate proceedings for rulemaking.  <br/>1316.23(b) - Petition for grant of confidentiality for research subjects.  <br/>1316.24(b) - Petition for exemption from prosecution for researchers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                 Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, VA 22152.                                                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              DEA Diversion Control Division                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1307.03 - Exception request filing.  <br/>1307.22 - Delivery of surrendered and forfeited controlled substances.  <br/>1310.21(b) - Sale by Federal departments or agencies of chemicals which could be used to manufacture controlled substances certification request.<sup>2</sup>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                         Drug Enforcement Administration, Attn: Diversion Control Division/DC, 8701 Morrissette Drive, Springfield, VA 22152.                                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DEA Regulatory Section                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                      |
|1301.71(d) - Security system compliance review for controlled substances.  <br/>1309.71(c) - Security system compliance review for List I chemicals.  <br/>1310.03(c) - Mail-Order reports involving transactions with nonregulated persons or exports.<sup>1</sup>  <br/>1310.05(b)(1) - Unusual or excessive loss or disappearance of listed chemicals.  <br/>1310.05(b)(2) - Reports of domestic regulated transactions in a tableting machine or an encapsulating machine.<sup>1</sup>  <br/>1310.05(c)(1) - Reports of imports and exports of a tableting machine or an encapsulating machine.<sup>1</sup>  <br/>1310.05(c)(2) - Report of declared exports of machines refused, rejected, or returned.  <br/>1312.12(a) - Application for import permit (DEA Form 357).<sup>1</sup>  <br/>1312.18(b) - Import declaration (DEA Form 236) submission.<sup>1</sup>  <br/>1312.22(g)(8) - Request for return of unacceptable or undeliverable exported controlled substances.<sup>1</sup>  <br/>1312.27(a) - Controlled substances export declaration (DEA Form 236) filing.<sup>1</sup>  <br/>1312.31(b) - Controlled substances transshipment permit application.  <br/>1312.32(a) - Advanced notice of importation for transshipment or transfer of controlled substances.  <br/>1313.12(b) - Authorization to import listed chemicals (DEA Form 486/486A).<sup>1</sup>  <br/>1313.12(e) - Quarterly reports of listed chemicals importation.  <br/>1313.21(b) - Authorization to export listed chemicals (DEA Form 486).<sup>1</sup>  <br/>1313.21(e) - Quarterly reports of listed chemicals exportation.  <br/>1313.22(c) - Notice of declared exports of listed chemicals refused, rejected or undeliverable.<sup>1</sup>  <br/>1313.31(b) - Advanced notice of importation for transshipment or transfer of listed chemicals.  <br/>1313.32(b)(1) - International transaction authorization (DEA Form 486).<sup>1</sup>  <br/>1314.110(a)(1) - Reports for mail-order sales.  <br/>1314.110(a)(2) - Request to submit mail-order sales reports.|                                            Drug Enforcement Administration, Attn: Regulatory Section/DRG, 8701 Morrissette Drive, Springfield, VA 22152.                                             |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          DEA Drug & Chemical Evaluation Section                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1308.21(a) - Exclusion of nonnarcotic substance.  <br/>1308.23(b) - Exemption for chemical preparations.  <br/>1308.24(d) - Exempt narcotic chemical preparations importer/exporter reporting.  <br/>1308.24(i) - Exempted chemical preparations listing.  <br/>1308.25(a) - Exclusion of veterinary anabolic steroid implant product application.  <br/>1308.26(a) - Excluded veterinary anabolic steroid implant products listing.  <br/>1308.31(a) - Exemption of a nonnarcotic prescription product application.  <br/>1308.32 - Exempted prescription products listing.  <br/>1308.33(b) - Exemption of certain anabolic steroid products application.  <br/>1308.34 - Exempted anabolic steroid products listing.  <br/>1310.13(b) - Exemption for chemical preparations.  <br/>1310.05(d) - Bulk manufacturer of listed chemicals reporting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                    Drug Enforcement Administration, Attn: Drug & Chemical Evaluation Section/DRE, 8701 Morrissette Drive, Springfield, VA 22152.                                     |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               UN Reporting & Quota Section                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1303.12(b) - Application for controlled substances procurement quota (DEA Form 250) filing and request.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                       Drug Enforcement Administration, Attn: UN Reporting & Quota Section/DRQ, 8701 Morrissette Drive, Springfield, VA 22152.                                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1303.12(d) - Controlled substances quota adjustment request.  <br/>1303.22 - Application for individual manufacturing quota (DEA Form 189) filing and request for schedule I or II controlled substances.  <br/>1304.31(a) - Manufacturers importing narcotic raw material report submission.  <br/>1304.32(a) - Manufacturers importing coca leaves report submission.  <br/>1315.22 - Application for individual manufacturing quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 189) filing and request.  <br/>1315.32(e) - Application for procurement quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 250) filing and request.  <br/>1315.32(g) - Procurement quota adjustment request for ephedrine, pseudoephedrine, and phenylpropanolamine.  <br/>1315.34(d) - Application for import quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 488) request and filing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1315.36(b) - Request import quota increase for ephedrine, pseudoephedrine, or phenylpropanolamine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Pharmaceutical Investigations Section                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1304.04(d) - ARCOS separate central reporting identifier request.  <br/>1304.33(a) - Reports to ARCOS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |Drug Enforcement Administration, Attn: ARCOS Unit/DOPT, P.O. Box 2520, Springfield, VA 22152-2520 OR Drug Enforcement Administration, Attn: ARCOS Unit, 8701 Morrissette Drive, Springfield, VA 22152.|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 DEA Registration Section                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1301.03 - Procedures information request (controlled substances registration).  <br/>1301.13(e)(2) - Request DEA Forms 224, 225, and 363.  <br/>1301.14(a) - Controlled substances registration application submission.  <br/>1301.18(c) - Research project controlled substance increase request.  <br/>1301.51 - Controlled substances registration modification request.  <br/>1301.52(b) - Controlled substances registration transfer request.  <br/>1301.52(c) - Controlled substances registration discontinuance of business activities notification.  <br/>1309.03 - List I chemicals registration procedures information request.  <br/>1309.32(c) - Request DEA Form 510.  <br/>1309.33(a) - List I chemicals registration application submission.  <br/>1309.61 - List I chemicals registration modification request.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                              Drug Enforcement Administration, Attn: Registration Section/DRR P.O. Box 2639, Springfield, VA 22152-2639.                                              |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DEA Hearing Clerk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1301.43 - Request for hearing or appearance; waiver.  <br/>1303.34 - Request for hearing or appearance; waiver.  <br/>1308.44 - Request for hearing or appearance; waiver.  <br/>1316.45 - Hearings documentation filing.  <br/>1316.46(a) - Inspection of record.  <br/>1316.47(a) - Request for hearing.  <br/>1316.48 - Notice of appearance.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                              Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, VA 22152.                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           DEA Federal Register Representative                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1301.33(a) - Filing of written comments regarding application for bulk manufacture of Schedule I and II substances.<sup>2</sup>  <br/>1301.34(a) - Filing of written comments regarding application for importation of Schedule I and II substances.<sup>2</sup>  <br/>1303.11(c) - Filing of written comments regarding notice of an aggregate production quota.<sup>2</sup>  <br/>1303.13(c) - Filing of written comments regarding adjustments of aggregate production quotas.<sup>2</sup>  <br/>1303.13(c) - Filing of written comments regarding adjustments of aggregate production quotas.<sup>2</sup>  <br/>1308.43(g) - Filing of written comments regarding initiation of proceedings for rulemaking.<sup>2</sup>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                    Drug Enforcement Administration, Attn: Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, VA 22152.  <br/>http://www.regulations.gov/.                     |

<sup>1</sup> Applications/filings/reports are required to be filed electronically in accordance with this chapter.

<sup>2</sup> Applications/filings/reports may be filed electronically in accordance with this chapter.

[81 97041, Dec. 30, 2016]